Q-omics provides the consensus-scored CFAP126 profile across patient tissues and cancer cell-line models. CFAP126 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in SCLC. Additionally, CFAP126 RNA expression shows 14,413 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight SCLC, and LSCC as cancer lineages where CFAP126 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for CFAP126 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes CFAP126 survival associations across molecular data types. CFAP126 RNA expression shows survival associations in the most cancer types (1), followed by mass-spec protein abundance (3). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

CFAP126 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
Protein (mass-spec)	Kaplan–Meier	3	LUAD (53)	view →
RNA	Kaplan–Meier	1	SCLC (26)	view →

This table ranks reproducible CFAP126 RNA expression–survival associations across cancer types. High CFAP126 expression shows unfavorable associations in SCLC. The SCLC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify SCLC as the clearest survival context for CFAP126 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Median	All	0.551	1.000	.002	26	view →

Pink = unfavorable, green = favorable. all 1 lineages →

CFAP126-SCLC (OS)

Kaplan–Meier survival curve for CFAP126 RNA expression in SCLC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with CFAP126 in patient tissues and cancer cell lines. In patient samples, CFAP126 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set. In cancer cell lines, CFAP126 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in PANCREAS, while CRISPR and shRNA rows add functional-dependency signals in LIVER and LARGE_INTESTINE.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	14,413	LSCC (5321)	view →
Function (mass-spec)	1,091	LSCC (457)	view →
▼Protein (mass-spec)
Protein (mass-spec)	4,154	UCEC (1918)	view →
RNA	1,792	UCEC (1199)	view →
▼Mutation
RNA	32	SKCM (16)	view →
Infiltrating cells	1	STAD (1)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼CRISPR
CRISPR	1,964	PANCREAS (223)	view →
RNA	1,341	LIVER (228)	view →
▼Mutation
Mutation	2,192	LARGE_INTESTINE (2192)	view →
RNA	11	LARGE_INTESTINE (11)	view →
▼RNA
RNA	2,044	LUNG_SCLC (554)	view →
shRNA	887	UPPER_AERODIGESTIVE_TRACT (117)	view →
▼shRNA
shRNA	1,443	SKIN (435)	view →
RNA	1,209	BREAST (331)	view →